The role of the immuno-inflammatory response in patients after cardiac arrest

Archives of Medical Science

Volumn 7, Issue 4, 2011, Pages 619-626

  Samborska Sablik, Anna ^a   Sablik, Zbigniew ^a   Gaszynski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

C reactive protein; Cardiac arrest; Interleukin; Post cardiac arrest syndrome; Survival

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APACHE; ARTICLE; ASYSTOLE; BLOOD SAMPLING; CARDIAC PATIENT; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CORRELATION ANALYSIS; DEATH; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HEART ARREST; HEART VENTRICLE FIBRILLATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; OUTPATIENT CARE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; UNCONSCIOUSNESS;

EID: 80052576004     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.24131     Document Type: Article

References (34)

1. Ali B, Zafari AM. Narrative Review: Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: Review of the Current Guidelines. Ann Intern Med 2007; 147: 171-9. (Pubitemid 351664598)
2. Neumar RW, Nolan JP, Adrie C, et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118: 2452-83.
3. Nolan JP, Laver SR, Welch CA, Harrison DA, Gupta V, Rowan K. Outcome following admission to UK intensive care units after cardiac arrest: A secondary analysis of the ICNARC Case Mix Programme Database. Anaesthesia 2007; 62: 1207-16. (Pubitemid 350060515)
4. Kouwenhoven WB, Jude JR, Knickerbocker GG. Closed-chest cardiac massage. JAMA 1960; 173: 1064-7.
5. No authors listed. Cardiopulmonary resuscitation. JAMA 1966; 198: 372-9.
6. Herlitz J, Bång A, Gunnarsson J, et al. Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: Change in outcome over 20 years in the community of Göteborg, Sweden. Heart 2003; 89: 25-30. (Pubitemid 36044284)
7. Brindley PG, Markland DM, Mayers I, Kutsogiannis DJ. Predictors of survival following in-hospital adult cardiopulmonary resuscitation. CMAJ 2002; 167: 343-8. (Pubitemid 35034628)
8. Negovsky VA. The second step in resuscitation: The treatment of the 'post-resuscitation disease'. Resuscitation 1972; 1: 1-7.
9. Shoemaker WC, Appel PL, Kram HB. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest 1992; 102: 208-15.
10. Cerchiari EL, Safar P, Klein E, Diven W. Visceral, hematologic and bacteriologic changes and neurologic outcome after cardiac arrest in dogs: The visceral post-resuscitation syndrome. Resuscitation 1993; 25: 119-36. (Pubitemid 23123636)
11. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 2002; 106: 562-8. (Pubitemid 34827705)
12. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C. Postresuscitation disease after cardiac arrest: A sepsis-like syndrome? Curr Opin Crit Care 2004; 10: 208-12. (Pubitemid 40104437)
13. Niskanen M, Kari A, Nikki P, et al. Acute physiology and chronic health evaluation (APACHE II) and Glasgow coma scores as predictors of outcome from intensive care after cardiac arrest. Crit Care Med 1991; 19: 1465-73.
14. Sandroni C, Barelli A, Piazza O, Proietti R, Mastria D, Boninsegna R. What is the best test to predict outcome after prolonged cardiac arrest? Eur J Emerg Med 1995; 2: 33-7.
15. Kruse JA, Thill-Baharozian MC, Carlson RW. Comparison of clinical assessment with APACHE II for predicting mortality risk in patients admitted to a medical intensive care unit. JAMA 1988; 260: 1739-42.
16. Beck DH, Taylor BL, Millar B, Smith GB. Prediction of outcome from intensive care: A prospective cohort study comparing Acute Physiology and Chronic Health Evaluation II and III prognostic systems in a United Kingdom intensive care unit. Crit Care Med 1997; 25: 9-15.
17. Ziakas A, Gavrilidis S, Giannoglou G, et al. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis. Angiology 2006; 57: 283-93. (Pubitemid 44438548)
18. Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB; Intermountain Heart Collaborative (IHC) Study Group. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 2002; 89: 145-9. (Pubitemid 34132900)
19. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K. C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur J Heart Fail 2005; 7: 748-54. (Pubitemid 41125888)
20. Yeh ET. CRP as a mediator of disease. Circulation 2004; 109 (Suppl 1): II11-4. (Pubitemid 38724150)
21. Pedersen BK. IL-6 signalling in exercise and disease. Biochem Soc Trans 2007; 35: 1295-7. (Pubitemid 350206483)
22. Smolen JS, Maini RN. Interleukin-6: A new therapeutic target. Arthritis Res Ther 2006; 8 Suppl 2: S5.
23. Fisman EZ, Benderly M, Esper RJ, et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 2006; 98: 14-8. (Pubitemid 43902673)
24. Luc G, Bard JM, Juhan-Vague I, et al PRIME Study Group. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: The PRIME Study. Arterioscler Thromb Vasc Biol 2003; 23: 1255-61. (Pubitemid 36871282)
25. Marciniak A, Gierbliński I, Stefański R, et al. Predictive value of plasma interleukin 1, interleukin 6, interleukin 8 and C-reactive protein (CRP) in patients with myocardial infarction. Pol Arch Med Wewn 2003; 109: 15-22. (Pubitemid 36188319)
26. Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 2006; 34: 2035-42. (Pubitemid 44305602)
27. Geppert A, Steiner A, Zorn G, et al. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 2002; 30: 1987-94.
28. Dennis VA, Jefferson A, Singh SR, Ganapamo F, Philipp MT. Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: A possible role for suppressors of cytokine signaling 1 and 3. Infect Immun 2006; 74: 5780-9. (Pubitemid 44484564)
29. Sappino AP, Alberto P. Tumor necrosis factor and cachectin. The same hormone with multiple effects. Ann Pathol 1987; 7: 239-41. (Pubitemid 18031575)
30. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFalpha in pulmonary pathophysiology. Respir Res 2006; 7: 125.
31. Tracey KJ, Cerami A. Metabolic responses to cachectin/TNF. A brief review. Ann N Y Acad Sci 1990; 587: 325-31. (Pubitemid 20249304)
32. Buxton AE, Lee KL, Hafley GE, et al.; MUSTT Investigators. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: Lessons from the MUSTT study. J Am Coll Cardiol 2007; 50: 1150-7. (Pubitemid 47375017)
33. Niemann JT, Garner D, Lewis RJ. Tumor necrosis factor-alpha is associated with early postresuscitation myocardial dysfunction. Crit Care Med 2004; 32: 1753-8. (Pubitemid 39050528)
34. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999; 43: 860-78. (Pubitemid 29413185)